Join Us! Wednesday, April 21 at 11am EST

CDG CARE is delighted to feature the first in a series of patient education webinars for our CDG/NGLY1 Community. In partnership with Putting Rare Diseases Patients First!®, a 501(c)(3) nonprofit charity, this first 2-hour, interactive event is titled: The ABCs of Clinical Trials for the CDG/NGLY1 Community.

Who Should Register

Designed for participants to hear from the experts about the latest approaches to treating and studying CDGs & NGLY1...

Patients
Parents
Caregivers
Healthcare Professionals

Register Today

What You'll Learn

Your participation in this FREE 2-hour program will help pave the path to new treatments by increasing the understanding around the importance of:

Natural History Studies,
Clinical Trials,
And the value patients bring to the process

What to Expect

The program will consist of four, 20-minute sessions, each provided by one of our expert speakers introduced below.

We are collecting participant questions prior to the event. There will be ample time for Q&A after each presentation.

Session One

Introduction to the drug development and regulatory process and steps to making new treatments available to the CDG/NGLY1 Community

Session Two

Learn about the benefits of participating in natural history studies & the different types of clinical trials, including how to find them

Session Three

Voice of the Patient in Clinical Trials - hear from a rare disease clinical trial patient and their experience through the process

Session Four

Building the Foundation for a Brighter Future Together - better data, better quality and better outcomes

Meet Our Speakers

Eva Morava-Kozicz, MD, PhD

Professor of Medical Genetics, Mayo Clinic Editor in Chief, Journal of Inherited Metabolic Disease

Andrew Edmondson, MD, PhD

Attending Physician, Human Genetics & Metabolism, Children's Hospital of Philadelphia

Christina Lam, MD

Attending Physician, Seattle Children's Hospital Assistant Professor, Department of Pediatrics, University of Washington School of Medicine

Lorna Speid, PhD, M.R.Pharm.S.

Founder & President, Putting Rare Diseases Patients First!

Stay in Touch

We encourage you to provide your information below to stay in touch and receive notices about future CDG CARE educational programs!

Thank you. We will be in touch again soon.

This program is made possible by a generous grant from Travere Therapeutics.